You are browsing content specific to your location, some treatments may not be available:

Call for an appointment:

+971 2 652 8000

Dr. Gurpreet
Dr. Gurpreet Singh Kalra
Medical Director, ART Fertility Clinics India

MD MSc EBCOG Accred. MRCGP Pg. Cert (Med Lead), FFMLM

Specialist in Reproductive Medicine & Surgery, Fellowship of Faculty of Medical Leadership and Management, UK

Dr Gurpreet Singh Kalra trained as Obstetrician and Gynaecologist in Norway, accredited by European Board and College of Obstetrics and Gynaecology (EBCOG). He trained as Specialist in Reproductive Medicine and Surgery in University of Oslo, Norway and University of Bristol, United Kingdom. He completed Masters in Reproduction & Development from University of Bristol, United Kingdom where he was awarded Michael Hull Memorial award for best research project on Anti-Mullerian hormone as a test of ovarian reserve and response in controlled ovarian stimulationDr Kalra is Honorary Academic Lecturer with Bristol Medical School, University of Bristol, United Kingdom where he is faculty and unit Co-lead for ART module on Masters course for Reproduction & Development.


Since 2017 to 2021 he has been working as Clinical Director at Wales Fertility Institute, United Kingdom and since 2011 Consultant Reproductive Medicine and Surgery at Wales Fertility Institute (NHS) and Singleton Hospital, Swansea Bay University Health Board, United Kingdom.


A visionary and strategic clinical leader with commitment to clinical risk management, quality, and outcomes improvement in health care. He has a proven record of successfully implementing several quality improvement projects with measurable gains. He is a passionate medical engagement expert with excellent communication skills to interpret patient and clinician’s needs. He is an accredited member of Q Community, a platform for quality improvement in the NHS and a Fellow of Faculty of Medical Leadership and Management, United Kingdom.


Danish
English
Hindi
Norwegian
Punjabi
Swedish
Gurugram, India

Experience

A fertility specialist and gynaecologist with over 25 years of experience of training and practice in Norway, Sweden and United Kingdom.

  • April 2017 – July 2021, Clinical Director & Consultant, Wales Fertility Institute (NHS), Neath Port Talbot Hospital and University Hospital of Wales, Cardiff
  • August 2015 – November 2018, Lead Consultant CREATE Fertility Bristol, Mild & Natural cycle IVF center, United Kingdom 
  • July 2018 – April 2019, Interim Associate Unit Medical Director Neath Port Talbot Delivery unit, ABM University Health Board
  • August 2020, Honorary Academic Lecturer, Bristol Medical School, University of Bristol. Since June 2021, appointed unit Co-lead, Assisted Reproduction, Masters in Reproduction and Development. 
  • May 2014 – July 2021, Consultant Gynaecologist and Fertility spacialist, Sancta Maria Hospital, Swansea.
  • January 2011 – July 2021, Consultant Reproductive Medicine and Minimal Access Surgery – Singleton hospital, Swansea Bay University health board, Swansea
     
  • MBBS, Government Medical College, Amritsar, Punjab, India, 1991
  • MD Obstetrics & Gynaecology, Specialist accreditation in Norway & Sweden, 2002
  • EBCOG accredited (European Board & College of Obstetrics & Gynaecology – European Union of Medical Specialists) 2002
  • Membership Royal College of General Practitioners (with Merit in communication skills), London, United Kingdom, 2004
  • CCT Specialist registration in Obstetrics & Gynaecology, General Medical Council, United Kingdom, 2007
  • MSc (with Merit), Reproduction & development, University of Bristol, United Kingdom, 2006-2007
  • Advanced training skills module in Subfertility and Reproductive Endocrinology, Royal College of Obstetrics and Gynaecology (ATSM RCOG), United Kingdom, 2008-2009
  • Senior Clinical Fellow Reproductive Medicine, St Michael’s Hospital, Under supervision of Professor Emeritus David J Cahill, University Hospitals Bristol NHS Foundation Trust, United Kingdom 2008-2009
  • Advanced training skills module in Benign Laparoscopic Surgery, Royal College of Obstetrics and Gynaecology (ATSM RCOG), United Kingdom, 2010-2011
  • British Fertility Society certified trainer in pelvic & fertility ultrasound scan, 2016
  • Post Graduate Certificate in Medical leadership programme (with Merit) – Academi Wales - University of Wales Trinity Saint David, United Kingdom, 2016-17
  • FFMLM - Fellowship Faculty of medical leadership and management, United Kingdom, December 2020
     
  • Kalra GS, Eskild A. Unødige cervix prøver hos unge kvinner”, Tidsskr Nor legeforen 2007: Vol 20; 127. Should young women under the age of 25 years be treated for cervical intraepithelial neoplasia?
  • Kalra GS. Antimüllerhormon ved behandling av ufrivillig barnløshet. Tidskre Nor Legeforen Nr. 5, 2009; 129:409-11. Anti-Mullerian hormone – a new marker in Sub fertility.  A review article published in The Journal of Norwegian medical association, in February 2009. 
  • Kalra GS. Nezhat's Video-Assisted and Robotic-Assisted Laparoscopy and Hysteroscopy. Book review. The Obstetrician & Gynaecologist, July 2015.
  • Kalra GS. Sub fertility:  Chapter 47 - Essential Human Life Cycle for Health Science Students, ed.  Webster S, Morris G, Kevelighan E. Wiley & Co., Chichester UK 2018.
  • Kalra GS, Campbell S, Nargund G. Ovarian reserve may be compromised after adnexal surgery. Are we sufficiently fertility focused in our surgical training? Facts Views Vis Obgyn, 2016, 8 (2): 97-101
  • Kalra GS, Cahill D. Direct optical bladeless entry (DOBE) is a safer primary laparoscopic entry technique. Gynecol Surg (2016) 13 (Suppl 1): S1-S453
  • A national presentation at annual conference of Norwegian gynaecological association at Alesund, Norway in 2007." Natural history of HPV - risk of cervical dysplasia". 
  • Invited Speaker at Indian Fertility Society conference on 14 December 2008 in Chandigarh, India, Fertivision 2008 - “Anti-Mullerian hormone as a marker of ovarian reserve and response in controlled ovarian hyper stimulation".
  • Role of AMH in regulation of ovarian folliculogenesis. Oral presentation accepted at the International Society of Gynaecological Endocrinology meeting in Florence, Italy, March 2012.
  • Direct Optical Bladeless Entry (DOBE) is a safer primary laparoscopic entry technique. Kalra GS, Cahill D. Invited oral presentation at European Society for Gynaecological Endoscopy, Brussels, October 2016.
  • ABM University Health Board Gynaecological laparoscopic surgery risk registry (GLSRR) for patient safety and healthcare improvement presented at the Institute of Healthcare Improvement London 2017. Published in BMJ conference proceedings April 2017.
  • Invited International faculty, presented lecture on Recurrent implantation failure. Apollo Cradle Conference, Bengaluru, India July 2019. A national annual fertility conference organized by Apollo hospitals, India. 
  • Invited to speak at the UNESCO Bioethics conference at Swansea University, on 15 October 2019, on Speak about Fertility technologies with focus on ethical and social aspects. 
  • Invited speaker on Clinical Risk Management, Webinar, Institute of Quality, Confederation of Indian Industry (CII), Government of India, on 10 January 2021.
  • Invited speaker on Medical Leadership, Webinar, Institute of Quality, Confederation of Indian Industry (CII), Government of India, on 28 February 2021.
     
  • Merit in Communications Skill, Membership of Royal College of General Practitioners (MRCGP), London, United Kingdom 2004. 
  • “Michael Hull memorial award” for best research project in MSc Reproduction & Development, University of Bristol, 2007. 
  • Shortlisted for NHS Wales’s national award for “Patient safety” category 2014. 
  • Winner ABM University Health Board, Swansea, United Kingdom, Values in Practice, Chairman’s award “Patient safety” category, November 2015.
  • Winner ABM University Health Board, Swansea, United Kingdom, Values in Practice, Chairman’s award “Clinician of the year” November 2016.
  • Pg. Cert with Merit, Clinical leadership & management, University of Wales Trinity Saint Davids, United Kingdom, 2017.
  • Patient Choice award, Wales Fertility Institute, Swansea Bay University Health Board,    December 2018.
     

Note: Doctor's schedule is subject to change, Please contact the clinic for more information